Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs768231616
rs768231616
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0242383
Disease:
Age related macular degeneration
0.010 GeneticVariation BEFREE This study suggests that a coding SNP in EPHX1 (Y113H) may be important in AMD and supports a previous observation of an association with exudative AMD. 15774926 2005
dbSNP: rs201934979
rs201934979
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0686347
Disease:
Tardive Dyskinesia
0.010 GeneticVariation BEFREE No significant differences in genotypes frequencies of the CYP2D6 C100T polymorphism were observed between patients with TD and without TD (Chi2=4.078, P>0.05), but patients with TD had a significant excess of the T allele compared with those without TD (Chi2=4.28, P<0.05). 16490169 2006
dbSNP: rs201934979
rs201934979
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C3714760
Disease:
Drug-induced tardive dyskinesia
0.010 GeneticVariation BEFREE The C100T polymorphism of the CYP2D6 gene and the C163A polymorphism of the CYP1A2 gene may be associated with neuroleptic drug-induced tardive dyskinesia in Chinese patients with schizophrenia. 16490169 2006
dbSNP: rs201934979
rs201934979
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0036341
Disease:
Schizophrenia
0.010 GeneticVariation BEFREE The C100T polymorphism of the CYP2D6 gene and the C163A polymorphism of the CYP1A2 gene may be associated with neuroleptic drug-induced tardive dyskinesia in Chinese patients with schizophrenia. 16490169 2006
dbSNP: rs768231616
rs768231616
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0699791
Disease:
Stomach Carcinoma
0.010 GeneticVariation BEFREE We found an increased risk of gastric cancer for homozygotes for C (histidine) variant in Y113H of EPHX1 (odds ratio, 1.91; 95% confidence interval, 1.19-3.07) compared with subjects with TC/TT. 17164366 2006
dbSNP: rs768231616
rs768231616
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0024623
Disease:
Malignant neoplasm of stomach
0.010 GeneticVariation BEFREE We found an increased risk of gastric cancer for homozygotes for C (histidine) variant in Y113H of EPHX1 (odds ratio, 1.91; 95% confidence interval, 1.19-3.07) compared with subjects with TC/TT. 17164366 2006
dbSNP: rs2069522
rs2069522
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0009402
Disease:
Colorectal Carcinoma
0.010 GeneticVariation BEFREE There was a suggestion of increased risk, albeit insignificant after correction for multiple testing, of CRC for individuals homozygous for CYP1B1 rs162558 and heterozygous for CYP1A2 rs2069522 (odds ratio [OR] = 1.36, 95% confidence interval [CI]: 1.03-1.80 and OR = 1.34, 95% CI: 1.00-1.79 respectively). 17615053 2007
dbSNP: rs2470890
rs2470890
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0009402
Disease:
Colorectal Carcinoma
0.010 GeneticVariation BEFREE Through an association study based on 1,023 cases and 1,121 controls, we examined the influence on CRC risk of environmental factors coanalyzed with combinations of six single nucleotide polymorphisms located in cytochrome P450 genes (c.-163A>C and c.1548T>C in CYP1A2, g.-1293G>C and g.-1053C>T in CYP2E1, c.1294C>G in CYP1B1, and c.430C>T in CYP2C9). 17627011 2007
dbSNP: rs762551
rs762551
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0236734
Disease:
Caffeine related disorders
0.100 GeneticVariation BEFREE We collected information on lifetime coffee drinking and we studied two genes: ADORA2A, which encodes the major receptor activity of caffeine in the brain (variants rs5751876 and rs3032740), and CYP1A2, which encodes the major rate-limiting step of caffeine metabolism (variants rs35694136 and rs762551). 18759349 2008
dbSNP: rs35694136
rs35694136
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0236734
Disease:
Caffeine related disorders
0.010 GeneticVariation BEFREE We collected information on lifetime coffee drinking and we studied two genes: ADORA2A, which encodes the major receptor activity of caffeine in the brain (variants rs5751876 and rs3032740), and CYP1A2, which encodes the major rate-limiting step of caffeine metabolism (variants rs35694136 and rs762551). 18759349 2008
dbSNP: rs762551
rs762551
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.050 GeneticVariation BEFREE Association of genotypes with breast cancer risk was evaluated using multivariate logistic regression, which suggested an altered risk for the following SNPs [gene, odds ratio (OR) and 95% confidence interval are shown]: heterozygote carriers of rs4917623 [CYP2C19, OR = 1.38 (1.04-1.84)], rs2066853 [AhR, OR = 1.34 (1.02-1.76)] and rs1857407 [ERRG, (OR = 0.72 (0.55-0.96)]; homozygote carriers of rs762551 [CYP1A2, OR = 2.75 (1.47-5.14)], rs4917623 [CYP2C19, OR = 1.48 (1.00-2.19) and rs945453 [ERRG, OR = 1.66 (1.04-2.65)]. 19415745 2009
dbSNP: rs762551
rs762551
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0678222
Disease:
Breast Carcinoma
0.050 GeneticVariation BEFREE Association of genotypes with breast cancer risk was evaluated using multivariate logistic regression, which suggested an altered risk for the following SNPs [gene, odds ratio (OR) and 95% confidence interval are shown]: heterozygote carriers of rs4917623 [CYP2C19, OR = 1.38 (1.04-1.84)], rs2066853 [AhR, OR = 1.34 (1.02-1.76)] and rs1857407 [ERRG, (OR = 0.72 (0.55-0.96)]; homozygote carriers of rs762551 [CYP1A2, OR = 2.75 (1.47-5.14)], rs4917623 [CYP2C19, OR = 1.48 (1.00-2.19) and rs945453 [ERRG, OR = 1.66 (1.04-2.65)]. 19415745 2009
dbSNP: rs762551
rs762551
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0236734
Disease:
Caffeine related disorders
0.100 GeneticVariation BEFREE The observed increased risk of PD among female but not male carriers of the rs762551 polymorphism of CYP1A2 and the interactions of caffeine with ESR1 rs3798577 and ESR2 rs1255998 may provide clues to explain the relationship between gender, caffeine intake, estrogen status and risk of PD and need to be replicated. 20304699 2010
dbSNP: rs762551
rs762551
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0030567
Disease:
Parkinson Disease
0.040 GeneticVariation BEFREE The observed increased risk of PD among female but not male carriers of the rs762551 polymorphism of CYP1A2 and the interactions of caffeine with ESR1 rs3798577 and ESR2 rs1255998 may provide clues to explain the relationship between gender, caffeine intake, estrogen status and risk of PD and need to be replicated. 20304699 2010
dbSNP: rs762551
rs762551
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0030567
Disease:
Parkinson Disease
0.040 GeneticVariation BEFREE CYP1A2 polymorphisms were not associated with PD risk; however, the coffee-PD association was strongest among subjects homozygous for either variant allele rs762551 (P(interaction) = 0.05) or rs2470890 (P(interaction) = 0.04). 21281405 2011
dbSNP: rs1278748858
rs1278748858
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.010 GeneticVariation BEFREE The results of the study suggest that NQO1 exon 6 proline187serine (C609T) and CYP1A2 exon 2 phenylalanine21leucine (C63G) polymorphisms do not play a significant role in breast cancer susceptibility in North Indian women. 21329464 2011
dbSNP: rs1278748858
rs1278748858
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0678222
Disease:
Breast Carcinoma
0.010 GeneticVariation BEFREE The results of the study suggest that NQO1 exon 6 proline187serine (C609T) and CYP1A2 exon 2 phenylalanine21leucine (C63G) polymorphisms do not play a significant role in breast cancer susceptibility in North Indian women. 21329464 2011
dbSNP: rs2470890
rs2470890
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0030567
Disease:
Parkinson Disease
0.010 GeneticVariation BEFREE CYP1A2 polymorphisms were not associated with PD risk; however, the coffee-PD association was strongest among subjects homozygous for either variant allele rs762551 (P(interaction) = 0.05) or rs2470890 (P(interaction) = 0.04). 21281405 2011
dbSNP: rs56160784
rs56160784
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0678222
Disease:
Breast Carcinoma
0.010 GeneticVariation BEFREE The results of the study suggest that NQO1 exon 6 proline187serine (C609T) and CYP1A2 exon 2 phenylalanine21leucine (C63G) polymorphisms do not play a significant role in breast cancer susceptibility in North Indian women. 21329464 2011
dbSNP: rs56160784
rs56160784
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.010 GeneticVariation BEFREE The results of the study suggest that NQO1 exon 6 proline187serine (C609T) and CYP1A2 exon 2 phenylalanine21leucine (C63G) polymorphisms do not play a significant role in breast cancer susceptibility in North Indian women. 21329464 2011
dbSNP: rs17861157
rs17861157
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0202236
Disease:
Triglycerides measurement
0.700 GeneticVariation GWASDB Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. 23063622 2012
dbSNP: rs17861157
rs17861157
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C1445957
Disease:
Serum total cholesterol measurement
0.700 GeneticVariation GWASDB Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. 23063622 2012
dbSNP: rs762551
rs762551
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C0006826
Disease:
Malignant Neoplasms
0.060 GeneticVariation BEFREE We studied the interactions of the CYP1A2 functional variants -3860G/A(rs2069514),-2467T/delT(rs3569413),-163C/A(rs762551)] with occupational/environmental carcinogenic exposures in the development of lung cancer in a case-control study nested in the Danish prospective cohort "Diet, Cancer and Health." 22749033 2012
dbSNP: rs762551
rs762551
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C1306459
Disease:
Primary malignant neoplasm
0.060 GeneticVariation BEFREE Genetic polymorphism (rs762551A>C) in gene encoding cytochrome P450 1A2 (CYP1A2) has been shown to influence the inducibility of CYP1A2 expression and thus might be associated with risk of several types of human cancer. 23157985 2012
dbSNP: rs762551
rs762551
Entrez Id: 1544
Gene Symbol: CYP1A2
CYP1A2
CUI: C1306459
Disease:
Primary malignant neoplasm
0.060 GeneticVariation BEFREE These results suggested that CYP1A2 rs762551 polymorphism is likely to be associated with susceptibility to cancer in Caucasians. 23157985 2012